Literature DB >> 8064305

Influence of hyperglycaemia on infarct size and clinical outcome of acute ischemic stroke patients with intracranial arterial occlusion.

D Toni1, M De Michele, M Fiorelli, S Bastianello, M Camerlingo, M L Sacchetti, C Argentino, C Fieschi.   

Abstract

We investigated the effects of hyperglycaemia on infarct size of 82 acute ischaemic stroke patients with angiographically diagnosed intracranial occlusion in middle cerebral artery territory. There were 9 diabetics, 40 non-diabetic hyperglycaemics and 33 non-diabetic normoglycaemics (mean age 67 +/- 8 SD years, male/female ratio 1:1). For each patient the infarct at CT was compared to that predicted from the location of the arterial occlusion. The extent of the infarct was then classified as equal to, smaller than and larger than estimated, taking a standard anatomical template of arterial territories as reference. The results were analysed separately according to the presence or absence of a collateral blood supply (CBS) at angiography. The clinical outcome at 30 days was also evaluated. The 35 patients lacking CBS had a high frequency of equal to estimated lesions (75%), without substantial differences among the three subgroups (72% of hyperglycaemics, 82% of normoglycaemics and 67% of diabetics; Fisher's exact test not significant for any of the pairwise comparisons). On the contrary, the 47 patients with CBS exhibited an overall predominance of smaller than estimated lesions (66%) but with a very uneven distribution among hyperglycaemics, normoglycaemics and diabetics (82%, 64% and 0%, respectively; p < 0.05 at Fisher's exact test for diabetics vs hyperglycaemics). Finally, the clinical outcome was bad (death and neurological impairment) in 89% of diabetics, 72% of hyperglycaemics and 54% of normoglycaemics (p < 0.05). These results suggest that in patients with intracranial arterial occlusion associated with CBS the effects of hyperglycaemia might be beneficial in non-diabetics and harmful in diabetics.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064305     DOI: 10.1016/0022-510x(94)90214-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  [Recommendations of the European Stroke Initiative (EUSI) for treatment of ischemic stroke--update 2003. I. organization and acute therapy].

Authors:  Sonja Külkens; Peter Arthur Ringleb; Werner Hacke
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

2.  Insulin and glucagon share the same mechanism of neuroprotection in diabetic rats: role of glutamate.

Authors:  Rami Abu Fanne; Taher Nassar; Samuel N Heyman; Nuha Hijazi; Abd Al-Roof Higazi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

3.  Honokiol suppresses the development of post-ischemic glucose intolerance and neuronal damage in mice.

Authors:  Shinichi Harada; Maya Kishimoto; Mana Kobayashi; Kazuo Nakamoto; Wakako Fujita-Hamabe; Hwei-Hsien Chen; Ming-Huan Chan; Shogo Tokuyama
Journal:  J Nat Med       Date:  2012-01-20       Impact factor: 2.343

4.  Morinda citrifolia fruit juice prevents ischemic neuronal damage through suppression of the development of post-ischemic glucose intolerance.

Authors:  Shinichi Harada; Wakako Fujita-Hamabe; Kohei Kamiya; Yoshiyuki Mizushina; Toshiko Satake; Shogo Tokuyama
Journal:  J Nat Med       Date:  2010-06-24       Impact factor: 2.343

5.  Persistent cerebrovascular damage after stroke in type two diabetic rats measured by magnetic resonance imaging.

Authors:  Guangliang Ding; Tao Yan; Jieli Chen; Michael Chopp; Lian Li; Qingjiang Li; Chengcheng Cui; Ruizhuo Ning; Quan Jiang
Journal:  Stroke       Date:  2014-12-18       Impact factor: 7.914

Review 6.  Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management.

Authors:  Nyika D Kruyt; Geert Jan Biessels; J Hans Devries; Yvo B Roos
Journal:  Nat Rev Neurol       Date:  2010-02-16       Impact factor: 42.937

Review 7.  Hyperglycemia / hypoglycemia-induced mitochondrial dysfunction and cerebral ischemic damage in diabetics.

Authors:  Ashish K Rehni; Neha Nautiyal; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Metab Brain Dis       Date:  2014-04-16       Impact factor: 3.584

Review 8.  Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair.

Authors:  Uma Maheswari Selvaraj; Katherine Poinsatte; Vanessa Torres; Sterling B Ortega; Ann M Stowe
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

9.  Early changes in physiological variables after stroke.

Authors:  Andrew A Wong; Stephen J Read
Journal:  Ann Indian Acad Neurol       Date:  2008-10       Impact factor: 1.383

10.  Various blood glucose parameters that indicate hyperglycemia after intravenous thrombolysis in acute ischemic stroke could predict worse outcome.

Authors:  Deok-Sang Yoo; Jane Chang; Joon-Tae Kim; Min-Ji Choi; Jina Choi; Kang-Ho Choi; Man-Seok Park; Ki-Hyun Cho
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.